{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-069380","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2023-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.209751+00:00","generated_at":"2026-06-07T14:49:00.172131+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Outset Medical borrows $33.5M under amended SLR term loan; total debt ~$133.5M","bullets":["On Dec 11, 2023, Outset amended its SLR term loan, restructuring the $100M Term B into two tranches: B-1 ($33.5M) and B-2 ($66.5M).","Outset borrowed the full Term B-1 tranche on the amendment date, increasing outstanding principal to ~$133.5M.","The Term A loan of $100M was drawn in Nov 2022; Term B-2 remains available subject to conditions.","No other material terms of the SLR term loan were changed by the amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-069380","json":"https://secwatch.observer/filing/0000950170-23-069380.json","markdown":"https://secwatch.observer/filing/0000950170-23-069380.md","text":"https://secwatch.observer/filing/0000950170-23-069380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/om-20231211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:49:00.172131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"512566945bfb94d2429765cbaefb50f55235a879","claim":"Outset Medical, Inc. incurred term loan of $100.0 million Term B Loans will be available in two tranches consisting of (i) Term B-1 Loans in the aggregate amount o with SLR Investment Corp., as collateral agent, the lenders from time to time party thereto.","evidence_excerpt":"The SLR Term Loan Amendment provides that the $100.0 million Term B Loans will be available in two tranches consisting of (i) Term B-1 Loans in the aggregate amount of approximately $33.5 million and (ii) Term B-2 Loans in the aggregate amount of approximately $66.5 million.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$100.0 million Term B Loans will be available in two tranches consisting of (i) Term B-1 Loans in the aggregate amount o"},{"label":"Counterparty","value":"SLR Investment Corp., as collateral agent, the lenders from time to time party thereto"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"d9d33bdafe366c78c1eb1daee7ceec936981d93c","claim":"Outset Medical, Inc. incurred term loan of Term B-1 Loans in the aggregate amount of approximately $33.5 million with SLR Investment Corp., as collateral agent, the lenders from time to time party thereto.","evidence_excerpt":"the Company borrowed and received the entire Term B-1 Loans from the Term Loan Lenders.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"Term B-1 Loans in the aggregate amount of approximately $33.5 million"},{"label":"Counterparty","value":"SLR Investment Corp., as collateral agent, the lenders from time to time party thereto"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"690be6fbe07df1ce5db2f698bda59bf6c05a6d02","claim":"Outset Medical, Inc. amended First Amendment to Loan and Security Agreement with SLR Investment Corp. valued at Amendment provides for $100.0 million Term B Loans in two tranches (B-1 ~$33.5M, B-2 ~$66.5M); borro (effective 2023-12-11).","evidence_excerpt":"On December 11, 2023 (the Amendment Effective Date), the Company amended the SLR Term Loan Facility pursuant to a First Amendment to Loan and Security Agreement (the SLR Term Loan Amendment) among the Collateral Agent, the Term Loan Lenders and the Company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"SLR Investment Corp."},{"label":"Value","value":"Amendment provides for $100.0 million Term B Loans in two tranches (B-1 ~$33.5M, B-2 ~$66.5M); borro"},{"label":"Effective","value":"2023-12-11"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}